1st Edition
Pharmacotherapies for the Treatment of Opioid Dependence Efficacy, Cost-Effectiveness and Implementation Guidelines
Opioid dependence and management
Pharmacology of opioid agonists and antagonists
Services for heroin withdrawal: A review
Methadone maintenance treatment
LAAM in the treatment of opioid dependence: A systematic review
The place of buprenorphine in the management of opioid dependence
Treating heroin dependence with diamorphine (pharmaceutical heroin)
Naltrexone maintenance treatment
Pharmacotherapies and pregnancy
Politics, practice, and research into treatment of heroin addiction
Clinical guidelines and procedures for the use of methadone in the maintenance treatment of opioid dependence
National clinical guidelines and procedures for the use of buprenorphine in the treatment of heroin dependence
Clinical guidelines and procedures for the use of naltrexone in the management of opioid dependence
Choosing treatments: The role of economics in informing future decisions
Biography
Richard P. Mattick, Robert Ali, Nicholas Lintzeris
"This succinct, well-organized book covers the relevant issues clinicians may need to address in treating patients for opiate withdrawal. It can be very useful for all healthcare providers involved in the clinical treatment of this patient population."
Michael Easton, MD - Rush University Medical Center (Doody Review, August 09)
"What the present book usefully adds to its predecessors are clinical guidelines for the use of opioid pharmacotherapies and a discussion of the cost-effectiveness of opioid therapies, helping the reader to make some assessment of the relative inexpensiveness of these therapies compared to other interventions and treatments in other settings.
I can see this will be a valuable book for clinicians and researchers who need a quick but reassuringly balanced and informed entry into the now extensive research supporting opioid prescribing. Busy policymakers may also find much of use in the book, if they have the time and the open mind to read it."
John Witton - National Addiction Centre, Institute of Psychiatry, King's College London (Reviewed in Druscope's journal, Druglink July 09)
